Keywords
Last Name
Institution
Children's Mercy Kansas City
More Search Options
Menu
Home
Find People
Find Everything
About This Site
Annual Report
Export RDF
Site Principal Investigator
Overview
researcher role of
Chavez-Bueno, Susana
contributes to
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness